- Details
An aldehyde-binding eye drop showed it can significantly reduce ocular itching and tearing.
Read more: Novel eye drop for allergic conjunctivitis shows promise
- Details
Medidur, an injectable insert that provides sustained release of flucinolone acetonide for 3 years, helps prevent recurrence of posterior uveitis.
Read more: Sustained-release corticosteroid for uveitis shows promise
- Details
This non-randomized clinical trial assessed the efficacy of 2% ibopamine, a topical drug that temporarily increases aqueous production, for diagnosing glaucoma.
Read more: Ibopamine challenge test can diagnose glaucoma stages
- Details
This retrospective review shows that the introduction of corneal collagen crosslinking may have reduced the number of keratoplasty procedures for keratoconus.
- Details
The FDA has issued a final guidance document for industry and FDA staff on minimally invasive glaucoma surgical (MIGS) devices.
- Details
Ocular Therapeutix announced promising topline results from a phase 2 clinical trial of sustained-released dexamethasone for inflammatory dry eye disease.
Read more: Sustained-released dexamethasone shows promise in dry eye